Kenneth Ferguson

Kenneth Ferguson

Director/Board Member at CYCLACEL PHARMACEUTICALS, INC.

68 year
Health Technology
Consumer Services
Finance

Profile

Kenneth M.
Ferguson
is currently the Director at Cyclacel Pharmaceuticals, Inc. and an Operating Partner at Accelerator Services Corp.
Previously, he was the President, Chief Executive Officer & Director at Vactx International, Inc. from 2008 to 2010, COO, Chief Scientific Officer & Director at Lilly ICOS LLC, and President at ICOS Corp.
from 1990 to 2007.
He also served as the Chief Development Officer & Vice President at Omeros Corp.
from 2012 to 2017 and as the Chief Scientific Officer at EMulate Therapeutics, Inc. Dr. Ferguson received his undergraduate degree from Cornell University and his doctorate from Texas University of Health Center at San Antonio.

Kenneth Ferguson active positions

CompaniesPositionStart
CYCLACEL PHARMACEUTICALS, INC. Director/Board Member 2022-06-13
Private Equity Investor -
All active positions of Kenneth Ferguson

Former positions of Kenneth Ferguson

CompaniesPositionEnd
OMEROS CORPORATION Corporate Officer/Principal 2017-04-30
Vactx International, Inc. Chief Executive Officer 2010-10-31
President 2007-11-30
Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
See the detail of Kenneth Ferguson's experience

Training of Kenneth Ferguson

Cornell University Undergraduate Degree
Texas University of Health Center at San Antonio Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth Ferguson's experience

Connections

83

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
OMEROS CORPORATION

Health Technology

CYCLACEL PHARMACEUTICALS, INC.

Health Technology

Private companies5

Health Technology

Health Technology

Health Technology

Finance

Vactx International, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Kenneth Ferguson
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW